Evaluating the Safety Profile of Semaglutide: An Updated Meta-Analysis

• المؤلفون الرئيسيون: Rivera, Frederick Berro, Arias-Aguirre, Eloise, Aguirre, Zedrick, Ybañez, Mc John C., Rubia, Janos Marc M., Galang, Danica Janine, Lumbang, Grace Nooriza, Ruyeras, Jade Monica Marie J., Magalong, John Vincent, Pine, Polyn Luz, Amigo, John Andrew C., Ansay, Marie Francesca M., Zelenkov, Nenad, Thomas, Steve Samuel, Vijayaraghavan, Krishnaswami
• التنسيق: text
• منشور في: Archīum Ateneo 2024
• الموضوعات: adverse events; glucagon-like peptide-1 receptor agonist; meta-analysis; obesity; safety profile; Semaglutide; type 2 diabetes mellitus; Diseases; Endocrine System Diseases; Medicine and Health Sciences
• الوصول للمادة أونلاين: https://archium.ateneo.edu/asmph-pubs/245; https://doi.org/10.1080/03007995.2024.2383731

Background Semaglutide is increasingly used in the management of type 2 diabetes mellitus and obesity. Ensuring the safety of this medication is crucial for its clinical use. This meta-analysis evaluates the safety profile of semaglutide across patient populations and treatment durations. Methods R...